MBRX

Moleculin Biotech, Inc.

$2.55+0.01 (0.39%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Moleculin Biotech, Inc. (MBRX) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

Showing 10 of 37 transactions (past 365 days)

MBRX
CFO
Award
$0
Foster Jonathan P.600,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
Director
Award
$0
Climaco John M150,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
Director
Award
$0
George Robert E.150,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
Director
Award
$0
Yan Joy150,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
Director
Award
$0
Cermak Elizabeth150,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
CEO
Award
$0
Klemp Walter V830,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
CSO
Award
$0
Picker Donald H200,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
CSO
Award
$0
Picker Donald H200,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
CFO
Award
$0
Foster Jonathan P.400,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12
MBRX
Director
Award
$0
Cannon Michael D150,000 shares @ $0.00
Filed 2025-11-14Trade 2025-11-12

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →